Clinical Trial Update: The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of exenatide on post-meal glucose peaks and vascular health in obese/pre-diabetic young adults has been withdraw…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Impaired Glucose Tolerance
• Insulin Resistance
• Obesity

Drugs mentioned

• BYETTA (Exenatide)
• Bydureon (exenatide)

Snippet

Sponsor: Yale University | Conditions: Obesity, Insulin Resistance | Phase 4 | Status: WITHDRAWN